Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Arogo Capital Acquisition A | AOGO | 4. oct 2024 | 11.00 | 0.00 |
Arq | ARQ | 4. oct 2024 | 5.71 | +4.39 |
Arqit Quantum | ARQQ | 4. oct 2024 | 4.31 | -3.58 |
Array Technologies | ARRY | 4. oct 2024 | 6.45 | +2.06 |
ArriVent BioPharma | AVBP | 4. oct 2024 | 27.26 | +6.40 |
Arrow DJ Global Yield ETF | GYLD | 4. oct 2024 | 13.71 | +0.44 |
Arrow Electronics | ARW | 4. oct 2024 | 130.95 | +1.24 |
Arrow Financial | AROW | 4. oct 2024 | 28.05 | +1.52 |
Arrowhead Pharmaceuticals | ARWR | 4. oct 2024 | 18.82 | -0.16 |
Arrowmark Financial | BANX | 4. oct 2024 | 20.34 | -0.68 |
ARS Pharmaceuticals | SPRY | 4. oct 2024 | 14.19 | +1.36 |
Artelo Biosciences | ARTL | 4. oct 2024 | 1.12 | -0.36 |
Arteris | AIP | 4. oct 2024 | 7.10 | 0.00 |
Artesian Resources A | ARTNA | 4. oct 2024 | 36.20 | +0.28 |
Arthur J. Gallagher & Co | AJG | 4. oct 2024 | 289.62 | +1.24 |
Artisan Partners Asset Management A | APAM | 4. oct 2024 | 42.90 | +2.78 |
Artiva Biotherapeutics | ARTV | 4. oct 2024 | 15.83 | 0.00 |
Artivion | AORT | 4. oct 2024 | 26.44 | +2.01 |
Arts-Way Manufacturing Co. | ARTW | 4. oct 2024 | 1.85 | +4.82 |
Arvinas | ARVN | 4. oct 2024 | 24.96 | +1.96 |
ASA Gold And Precious Metals | ASA | 4. oct 2024 | 20.88 | +0.77 |
Asana | ASAN | 4. oct 2024 | 11.53 | +2.95 |
Asbury Automotive Group | ABG | 4. oct 2024 | 231.82 | +3.72 |
Ascendis Pharma ADR | ASND | 4. oct 2024 | 142.67 | +1.22 |
Ascent Industries | ACNT | 4. oct 2024 | 9.64 | -1.63 |
Ascent Solar Technologies | ASTI | 4. oct 2024 | 2.59 | +3.19 |
ASE Technology ADR | ASX | 4. oct 2024 | 9.84 | +1.44 |
ASGN | ASGN | 4. oct 2024 | 94.26 | +1.81 |
Ashford Hospitality Trust | AHT | 4. oct 2024 | 0.73 | -0.26 |
Ashford Hospitality Trust G Pref | AHT-G | 4. oct 2024 | 16.50 | -3.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.